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Abstract
Experiments of pain with human subjects are difficult, subjective, and ethically constrained. Since
the molecular mechanisms of pain transduction are reasonably conserved among different species,
these problems are partially solved by the use of animal models. However, animals cannot easily
communicate to us their own pain levels. Thus progress depends crucially on our ability to quan-
titatively and objectively infer the perceived level of noxious stimuli from the behavior of animals.
Here we develop a quantitative model to infer the perceived level of thermal nociception from the
stereotyped nociceptive response of individual nematodes Caenorhabditis elegans stimulated by an
IR laser. The model provides a method for quantification of analgesic effects of chemical stimuli or
genetic mutations in C. elegans. We test the nociception of ibuprofen-treated worms and a TRPV
(transient receptor potential) mutant, and we show that the perception of thermal nociception for
the ibuprofen treated worms is lower than the wild-type. At the same time, our model shows that
the mutant changes the worm’s behavior beyond affecting nociception. Finally, we determine the
stimulus level that best distinguishes the analgesic effects and the minimum number of worms that
allow for a statistically significant identification of these effects.
Introduction
Pain is a common health problem that causes over $60 billion a year in productivity losses in the United
States [1]. Research on pain sensing (also known as nociception) with human subjects is difficult for a
number of reasons including ethical constraints, difficulties in quantifying a psychophysical response, and
subjectivity in self-reporting [2]. Since the molecular mechanisms of pain transduction are believed to be
partially conserved among many different species [3, 4, 5], some of these problems are solved by using
animal models in nociception research. However, animal subjects cannot communicate their perceived
pain levels to us in an obvious fashion. Thus progress in using animal models depends crucially on our
ability to quantitatively and objectively infer the perceived level of noxious stimuli from animal behavior.
Historically, studies of pain primarily used mammalian models [6, 7]. For rodents, the tail flick test
[8], the hot-plate test [9, 10] and the Hargreaves’ method [11] correlate pain perception with the reaction
latency of different body parts to noxious stimuli. For larger animals such as canines [12] and primates
[13, 14], similar nociceptive assays have also been developed. In recent years, new approaches started
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incorporating facial expressions in nociception quantification [15, 16, 17]. Although these mammalian
models are extensively studied, several drawbacks hinder their use. First, ethical issues and risks arise for
certain experiments. Second, compared to lower-level organisms, mammalian subjects require more time
and resources to maintain. Therefore, much effort has been devoted to investigations of the possibility
of using invertebrate models in nociception research [4, 18]. In experiments involving Drosophila larva,
measures such as the response percentage of the total population [19, 20] and the time to response [21]
have been used to investigate changes in the ability of the animals to sense noxious stimuli. In experiments
on Caenorhabditis elegans, behavioral features such as the turning rate [3] and the percentage of escape
response [22] have been used to characterize nociception.
All of these models share some common problems. First, the nociceptive assays focus on one particular
coarse behavioral feature of the subject, such as avoidance behavior, orientation, or turning rate. Such
features are selected in an ad hoc fashion, subject to a particular design of an experiment. This makes it
difficult to compare results across different labs and experiments. Further, the behavior may be providing
additional information about the perceived pain that is not being captured by the coarse measures.
Second, some assays report measurements as a percentage of a population, so that these measurements
cannot be made for individuals. To overcome these problems, an ideal assay would infer a perceived pain
level of an individual animal on a continuous scale, using comprehensive, objective measurements of its
behavioral profile.
An even more important problem is that one would like to use the assays to calibrate the perceived
pain level, and maybe even reductions in such levels due to effects of analgesic drugs, or mutations in the
nociceptive pathways. At the same time, drugs or mutations can affect the motor response, rather than
the nociception per se. Thus traditional pain assays mentioned above may convolve the perceived pain
reduction, if any, with behavioral changes. For example, a mutant defective for turning behavior will
register a strong reduction in the turning rate, but it would be a mistake to interprete this as a reduction
in the pain perception. Such concerns are very real, as is illustrated by a known fact that opiods can
cause large behavioral changes, and thus they have effects beyond analgesic ones [23]. To attribute a
behavioral response difference to reduced nociception and not to motor changes, the response must be
stereotyped and reflexive, which is often the case [7]. Further, only the response amplitude or frequency,
but not the detailed temporal structure, should change in response to a drug or a mutation. Establishing
the stability of the stereotypic response pattern requires analysis of the entire response behavior, rather
than of its few selected features, as is done by most behavioral assays.
In this work, we address these issues in the context of the nematode C. elegans, developing it further as
an animal model system for nociception research. The worm is a great model organism for such studies
for a number of reasons. First, the behavioral dynamics of freely moving C. elegans is intrinsically
low dimensional [24]. This makes quantification of its behavioral response relatively straightforward,
providing an opportunity to use the entire motile behavior as a basis for assays. Second, the worms show
a noxious response to a wide range of sensations including certain types of chemical [25, 26], mechanical
[27, 28], and thermal [29, 30] stimuli, and such nociceptive response is different from and is transduced
independently of the related taxis behaviors [31, 32, 33, 34]. Third, at the molecular level, many details
of thermal nociception in the worm may be similar to vertebrate animals [4]. Fourth, there are powerful
genetic and optical tools to reveal mechanisms of nociception in C. elegans. Finally, the low cost, small
size, and absence of ethical constraints make the animal amenable to large scale pharmacological screens
for new analgesics [35].
We present combined experimental and modeling studies that show that the entire temporal behavioral
profile during the thermal nociceptive response in C. elegans is highly stereotypical, with the frequency
of the escape response and the amplitude of the escape velocity profile scaling with the stimulus level. By
verifying the ability of the behavioral template to capture the response following a nociceptive stimulus,
the model we develop distinguishes changes in nociception from changes to the motor program. When a
change is attributed to nociception, the model can infer the reduction in the perceived thermal nociception
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level following pharmacological or genetic treatments from the behavior of an individual worm. This
quantification requires only a handful of worms (about 60) to show statistically significant nociception
reduction for a common analgesic, and its statistical power quickly improves with an increasing number
of subjects.
The paper is organized as follows. First we discuss the structure of the dataset and the model. Then
we evaluate the performance of the model and discuss the stereotypical behavior we discovered. Further,
we use the model to infer the nociceptive stimulus level of worms in three different conditions: wild-type
untreated, wild-type treated with ibuprofen, and a mutant with defects in thermal nociception. We
argue that, while effects of the ibuprofen treatment can be attributed largely to a reduced nociception,
the mutant’s response shows changes to the behavior beyond nociceptive effects. Finally, we use the
statistical model to discuss how the nociception experiments should be designed to achieve the highest
statistical power to quantify analgesic effects.
Results
We aim to infer the perceived worm nociception level from the temporal dynamics of the worm response.
The noxious signal is administered by thermal stimulation using an infrared laser while the worm crawls
on an agar plate. The worm motion is captured by video microscopy and analyzed using custom image
analysis software. The worm postures are very stereotypical, adding up to simple sinusoidal motions
forwards or backwards, and to turns [24]. Thus without much loss to the statistical power, we characterize
the entire nociceptive behavior of the animal by a time series of its center of mass velocity (see Materials
and Methods). Our task is then to verify if such responses are stereotypical, scaling in frequency and
amplitude with the applied laser current. If they are stereotypical and thus can be used to characterize
the perceived nociception, the next task is to infer the applied laser current from the velocity data.
For each noxious stimulus trial a random worm is selected on the plate and its motion is sampled
at 60 Hz for 15 s. An infrared laser pulse with a randomly chosen current between 0 to 200 mA and a
duration of 0.1 s is then directed to the head of the worm 1 s after the start of the video recording. The
worm’s center of mass motion in a typical trial consists of a forward motion before the stimulus, a stop
and/or backwards motion after the stimulus, then followed by an “omega” turn, after which the worm
emerges with a forward motion in a different direction, cf. Fig. 1. This is a typical response to many
noxious stimuli in C. elegans, and not just to thermal noxious stimulus [30]. Such nociceptive response,
at least at large stimuli levels, is different from the more commonly studied thermotactic behavior, and
is mediated by different neural and genetic pathways [29, 30].
To understand the effects of pharmacological and genetic interventions on nociception transduction,
we collected three distinct datasets. In the first, the stimulus was applied to wild-type worms (N2). In the
second, the wild-type worms were pre-treated with an ibuprofen solution (see Materials and Methods).
In the third, we applied the stimulus to an untreated triple mutant (ocr-2(ak47) osm-9(ky10) IV; ocr-
1(ak46)). Hereafter we refer to these datasets as “control”, “ibuprofen”, and “mutant”, respectively.
We collectively refer to ibuprofen and mutant worms as “treated” worms. Forward motion in all three
data sets was similar (typical forward velocity of 13 ± 9, 9 ± 7, 13 ± 10 pixel/s respectively, where the
error denoted the standard deviation of the velocity distribution), so that there are no drastic defects in
motility.
Statistical model of the nociception
We bin the laser current of the nociceptive stimulus into five distinct levels (bins), defined to have
an equal number of control worms in each bin (40 per bin). The maximum reverse escape velocity is
indistinguishable among all three worm types for the largest stimulus level, indicating again no gross
defects to motility or noxious response. At the same time, the velocity at smaller stimuli levels shows
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Figure 1. Typical center-of-mass thermal nociception responses in C. elegans. (A) Typical
center-of-mass trajectory of two wild-type worms in a paused and an active state (see below for the
detailed discussion of the two states). The infrared laser was directed at each worm at t = 1 s. The
paused state is characterized by the near zero velocity after the laser stimulus. (B) Actual trajectories
of these two worms. Worm changes its direction of motion in two ways: in a “reversal”, it stops and
backtracks along its previous path; in an “omega” turn the worm’s head curls back and crosses the tail,
setting then a new direction of forward motion.
substantial differences (Z scores of up to 3.8) between the control and the treated worms, especially in
the vicinity of ∼ 100 mA laser stimulation, see Fig. 2(A). Mutant worms are especially different from the
control over a wider stimulus range. However, as discussed above, it is unclear if such simple observed
behavioral differences are indicative of the reduction of the perceived nociception level or of other changes
to the motor response.
To address this, instead of subjectively segmenting the complex escape behavior or choosing ad hoc
metrics of the worm’s movement, we choose to infer the applied stimulus strength from a comprehensive
model of the entire worm’s response velocity profile. Due to the considerable randomness and individual
variability of responses, we choose to model them probabilistically. Thus we are interested in estimating
P (I|v), the probability distribution of the applied laser current I conditional on the observed velocity of
the escape response v ≡ {v(t)}. Using Bayes’ theorem, we write
P (I|v) = P (v|I)P (I)
P (v) =
1
Z
P (v|I)P (I), (1)
where Z is the normalization factor, and P (I) is the prior distribution of stimuli. When we characterize
the velocity profiles of the noxious response of C. elegans, we notice that the worm can react to the
stimulus in two different ways. Some worms pause after the thermal stimulus, even at large laser currents
(see Fig. 2 (B)). These worms remains largely immobile for a few seconds, sometimes as long as the
recording duration. Other worms actively reverse and follow the classic escape behavior as shown in
Fig. 1. We choose to separate the active vs. the paused worms with a cutoff of 10 pixels/s, where 50
pixels is about one body length of the worm. To account for this heterogeneity in the behavior, we
introduce the state variable s, which can take one of two values, a or p, for each individual worm. Then
P (v|I) = P (v|s = p, I)P (s = p|I) + P (v|s = a, I)P (s = a|I). (2)
We model the probability of the paused state P (p|I) by a sigmoid function, cf. Fig. 2(C),
P (s = p|I, I0) = 11 + (I/I0)2 , (3)
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Figure 2. Global characteristics of the nociceptive escape. (A) The mean (± s. e. m.) of the
maximum reverse speed for the three worm types is plotted against the stimulus laser current,
partitioned into five bins. Negative values correspond to backward motion. (B) Maximum reverse
speeds for individual control worms. We define an active worm (dot) as having the maximum reverse
speed of over 10 pixels/s (about 0.2 body length per second); otherwise the worm is paused (plus sign).
(C) Probability of the paused state vs. the laser current. Dots represent the actual data (± s. e. m.),
and lines are the fitted model. The datasets are divided into equally sampled bins for each worm type.
where I0 is the pause current threshold. Then the probability of the active state is
P (s = a|I, I0) = 1− P (s = p|I, I0) = (I/I0)
2
1 + (I/I0)2 , (4)
We infer I0 from data by maximizing
∏Ntype
i=1 P (si|Ii, I0), where Ntype is the number of trials with worms
of the analyzed type, and Ii is the actual laser current for a particular trial. Note that each of the three
data sets has its own pause current (25.9± 2.8, 26.6± 1.9, and 51.6± 6.3 mA for the control, ibuprofen,
and mutant worms, respectively). Changes in this threshold, like that for the mutant, will result in
different numbers of worms responding to the same stimulus, which can be consistent with the changes
in the nociception level, depending on whether the response profiles themselves stay stable. This is what
we investigate next. Parenthetically, we note that the fraction of active worms is essentially the same as
the percentage of the escape response, which has been used previously to quantify worm nociception [22].
Here we go further and additionally analyze the behavioral profiles of the responding worms.
C. elegans locomotion consists of a series of stereotyped postures and behavioral states [36, 37].
Further, in other animals, nociceptive responses are stereotyped as well [7]. Therefore, it is natural to
explore if the nociceptive response of C. elegans is also stereotyped, separately for the paused and the
active states. For paused worms, the escape velocity is small and independent of the laser current, and
we model it as a multivariate normal variable,
P (v|p, I) = 1
(2pi)T2 |Σp| 12
exp
[
−12(v− up)
TΣ−1p (v− up)
]
, (5)
where up is the mean velocity profile of the paused worms measured from data, which we call the paused
template velocity. Σp is the empirical covariance of the paused velocity, and T is the total number of
effectively independent time points in the velocity profile time series, determined using the autocorrelation
structure of the profile (see Materials and Methods).
We expect that, in the active state, the worm escape is laser current dependent. Specifically, we seek
to represent it by a current-dependent rescaling of a stereotypical escape velocity, v ∼ f(I)ua, where f
5
is the scaling function, and ua is the active template velocity. Since various features of the worm escapes
(the maximum reverse speed, the maximum reverse acceleration, and the time to the omega turn), scale
non-linearly and saturate with the laser current (cf. Fig. 2(A)), the rescaling, f(I), must be sigmoidal.
Further, some worms have nonzero velocities even at zero laser current, so that f(0) may be nonzero.
Finally, the overall scale of the template can be absorbed in the definition of ua. The simplest scaling
function obeying these constraints has only two parameters
f(I) ≡ fI1,I2(I) = I1 +
I
1 + I/I2 , (6)
where I1 and I2 are again constants, different for the three different worm types. With this, we write the
probability of a velocity profile given the laser current I for the worm in an active state as a multivariate
normal distribution
P (v|a, I) = 1
(2pi)T2 |Σa| 12
× exp
[
−12(v− fI1,I2(I)ua)
TΣ−1a (v− fI1,I2(I)ua)
]
, (7)
where Σa is the covariance of the average velocity profile. We find the constants I1 and I2, ua and Σa
by maximizing the likelihood of the observed data (see Materials and Methods).
In summary, the probability of a velocity profile given the laser current in a certain trial is
P (v|I) =
{
1
1 + (I/I0)2 ×
1
(2pi)T2 |Σp| 12
exp
[
−12(v− up)
TΣ−1p (v− up)
]}
+
{
(I/I0)2
1 + (I/I0)2 ×
1
(2pi)T2 |Σa| 12
exp
[
−12(v− fI1,I2(I)ua)
TΣ−1a (v− fI1,I2(I)ua)
]}
. (8)
The overall model of the experiment, Eq. (1), also includes P (I). To a large extent, this is controlled by
the experimentalist, and details are described in Materials and Methods.
Is the nociceptive escape stereotyped?
The model we built assumes a stereotypical nociceptive response. Is this assumption justified? Velocities
in the paused state are very small (worms barely move). Thus whether the stereotypy assumption
provides a good model of the data is determined largely by the stereotypy of the active worms. If the
active stereotypical response template exists, then it should be possible to collapse the average velocity
profiles onto a single curve by the following transformation
vcollapse =
va
fI1,I2(I)
. (9)
Figure 3 confirms this: the means of different bins collapse relatively compactly, providing evidence for
the existence of the stereotypy in active nociceptive responses. We illustrate the template velocities and
the non-linear scaling function f inferred from the control, ibuprofen, and mutant in Fig. 4.
Note that the three active template velocity profiles in Fig. 4(A) are very similar, but the mutant
template velocity profile shows a response lag of 83 ms (one time frame at 12 Hz) compared to the
control or ibuprofen data set. In other words, the pharmacological treatments and the mutations weakly
affect the templated response, save for possibly delaying it. This bodes well for the assumption of the
stereotypical response, definitely for ibuprofen and, to a somewhat lesser extent, for the mutant.
While the existence of the stereotypical patterns and their similarity across treatments is encouraging,
we still need to quantify how good the statistical models are. In the ideal case, the variance σ2collapse of
the collapsed velocities, Eq. (9), calculated over individual trials, would be zero. However, there are a
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Figure 3. Collapse of the nociceptive response. (A) The mean and standard deviation of
velocities of active control worms, binned for presentation purposes into five different groups of 40
worms each, based on the stimulus current. (B) The mean and standard deviation of velocities in the
same time period rescaled by f−1I1,I2(Ii). Rescaled mean velocities nearly collapse. Note that the
parameters I1 and I2 are optimized as in Materials and methods to collapse individual profiles, and not
the five mean profiles illustrated here.
number of expected sources of variance in the velocity, such as the individual variability and the model
inaccuracies. To establish how good the stereotypical model fits are, we need to disambiguate these
contributions. For this, we again partition all velocity profiles into five current bins. We then write the
total variance of all responses as
σ2total = σ2I + σ2ind, (10)
where σ2ind is the variance due to individual responses within each bin, and σ2I is the current-driven
variance of the mean responses across the bins. Since the individuality of the worms is not accounted for
in our model, σ2I represents the maximum potentially explainable variance in the data. The stereotypy-
based model would be nearly perfect if σ2I were to drop to zero after the f−1 rescaling. To explore this,
in Fig. 5, we plot the total variance of the active response σ2total, panel (A), and the fraction of the
potentially explainable variance, σ2I/σ2total, panel (B). The latter varies from 20% to 40% of the total
variance, depending on the time post-stimulus and on the treatment. In both panels, the mutant and the
control dataset are nearly indistinguishable, while the ibuprofen worms show a smaller variance, and a
smaller fraction of the explainable variance. This is consistent with a smaller stimulus-driven nociceptive
response for this analgesic treatment. At the same time, these figures suggest that the decrease in the
maximum reverse speed in the mutant worm, Fig. 2 (A), should not be attributed entirely to the reduced
nociception. Indeed, the similarity of the variance and the explainable variance in the control and the
mutant worms, which have very different mean maximum reverse velocities, suggests existence of an
additional (explainable, non-templated) component in the nociceptive response of the mutant, which is
not present in the control.
The explainable variance σ2I is further split into the variance explained by the model, σ2m, and the
residual variance, σ2res, which the model fails to explain:
σ2I = σ2m + σ2res. (11)
In Fig. 5 (C), we plot σ2res/σ2I , which is the fraction of the variance not captured by our model. Of the
explainable variance, about 80% is captured by our model for the control and the ibuprofen worms in the
window between 1 s and 3.3 s since the start of the trial, on average. This is a relatively large fraction
for behavioral data, and provides an additional validation for our choice of a stereotypy-based model
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Figure 4. Stereotypical active nociceptive response. (A) Paused template velocities. Error bars
show the standard deviation of the template. Models are estimated separately for the three different
worm types, indicated by different colors. Time t = 1 s corresponds to the moment of the stimulus
application. (B) Normalized active template velocity. Each template velocity is normalized by the
absolute value of its minimum |mint va|. The error bars represent the model standard deviation,
estimated by bootstrapping (see Materials and Methods). The subfigure shows the template velocities
adjusted by the time of maximum reverse velocity, illustrating that the three templates nearly match.
(C) The rescaling function fI1,I2(I) for the three different worm types, normalized by multiplying by
the absolute value of the minimum of the active template velocity |mint va|. The optimized parameter
values are I1 = −4.5,−4.5, 66.5 and I2 = 45.0, 12.0,∞ for the control, ibuprofen, and mutant worms,
respectively. We deliberately do not report error bars on individual parameters, but rather show the
one standard deviation confidence intervals for the entire rescaling curve as shaded regions on the
figure. The confidence region was again estimated using bootstrapping.
for representing nociceptive escape behavior in these worms. Stability of the template itself between
these two conditions, and the stability of the fraction of the explained variance suggest that much of the
effect of ibuprofen can be attributed to scaling of the templated response (and also the fraction of active
worms). In other words, ibuprofen decreases the sensed nociception.
In contrast, the unexplained variance for the mutant is about twice as large as that for the control,
and approaches 100% at t > 2.7 s. This again illustrates that the templated response model is not very
good for this treatment. Thus the mutations introduce changes in the behavior that are not consistent
with a simple rescaling – mutations affect the fine motor behavior in addition to nociception per se.
Using the statistical model
One of the goals of our study is to develop methods for quantitative assessment of the efficacy of phar-
macological interventions to decreases sensed nociception, at least in those cases where their action can
be specifically interpreted as a change in nociception transduction. We can use the developed statistical
model for this. Specifically, taking the model derived from the control worms, we can infer the laser
current from behavior of all three different worm types. To the extent that the current inferred for the
treated worms is smaller than that for the control worms at the same applied current, the nociception
level perceived by the treated worms is smaller.
Figure 6 shows the overall structure of the inference done with the model. In the first row, we plot
the conditional distribution of the inferred laser current given the actual applied current I for the three
worm types, P (Iinf |I, type). For presentation purposes, we again bin the trials using Ii into five bins Iµ,
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Figure 5. Variability of the active nociceptive response. For the three worm types, in (A) we plot the
total variance of velocity profiles σ2total. Note that these numbers depend strongly on the preprocessing
of the data – in particular, smoothing of the velocity (with the 500 ms filter, see Materials and
Methods) decreases the total variance. In (B) we show the fraction of potentially explainable variance
σ2I/σ
2
total. Finally, (C) shows the part of the explainable variance that was not explained by our
statistical model σ2res/σ2I . See the main text for the discussion of the differences between the three
worm types on this plot.
µ = 1, . . . , 5 as before, and plot
P (Iinf |Iµ, type) =
Ntype∑
i
Pcontrol(Iinf |vi)Ptype(vi|Iµ). (12)
Here Ptype(vi|Iµ) is 1 if the stimulus on the i’th trial for this worm type was in the Iµ bin, and zero
otherwise. Further, Pcontrol(Iinf |vi) is given by the full model, Eq. (8), with the parameters inferred for
the control worm, and with the empirically observed velocities v in trial i for each worm type. We see that
there is more probability concentrated at small Iinf for the ibuprofen and the mutant worms, suggesting
a reduction in the perceived stimulus level. Similarly, in the second row in Fig. 6, we plot the expected
value, I¯i, of the distribution of the current inferred using the control model, Pcontrol(Iinf |vi), for each of
the individual trials in each of the three worm types. To the extent that the dots for the ibuprofen and
the mutant worms are again somewhat lower than for the control worms, there is some reduction in the
perceived current by this measure as well.
However, these population averaged results wash out important differences in the structure of the
nociception response. To quantify these small effects more accurately, we now look at the perceived
stimulus changes for individual worms in the datasets. Specifically, for each trial i in the control dataset,
a trial j(i) with the closest value of the applied laser current is found in the ibuprofen / mutant dataset
(the mean magnitude of the current mismatch is < 1 mA for both the ibuprofen and the mutant worms).
We then use the control model to calculate the expected value of the inferred current for the jth trial
in the ibuprofen / mutant datasets. This expectation is subtracted from the expectation value of the
inferred current for the matched trial i for the control dataset. The difference of the expectation values,
averaged over all control worms, is our measure of the reduction in the perceived nociception level
∆Itype =
1
Ncontrol
Ncontrol∑
i
(
Ii,control − Ij(i),type
)
. (13)
We evaluate ∆Itype for different worm types and for controls worms binned into the five usual current
bins, and show the results in Fig. 7. To estimate the error of ∆Itype, we bootstrap the whole analysis
9
In
ffe
re
d 
la
se
r c
ur
re
nt
 (m
A)
0
50
100
150
Actual laser current (mA)
20 51 77 100 139
A
0
50
100
150
Actual laser current (mA)
21 51 81 112 144
B
0
50
100
150
Actual laser current (mA)
28 59 109 148 179
C
0
0.005
0.01
0.015
0.02
Actual laser current (mA)
0 50 100 150 200I
nf
er
re
d 
la
se
r c
ur
re
nt
 (m
A)
0
50
100
150
200 D
Actual laser current (mA)
0 50 100 150 200
0
50
100
150
200 E
Actual laser current (mA)
0 50 100 150 200
0
50
100
150
200 F
Deviance = 9.8
Figure 6. Inferring the perceived nociception level from C. elegans nociceptive behavior.
The first row shows the heat maps of the conditional distributions of the inferred current vs. the actual
applied current, partitioned into five bins, Pcontrol(Iinf |Iµ). Inference is done with the model of the
control worm behavior. Panels (A), (B), (C) show the results for the control, ibuprofen, and mutant
worms, respectively. The second row shows the expected inferred laser current for each trial, I¯inf,i vs.
the applied current Ii. The inference is again done using the control model, and panels (D), (E), (F)
show the three worm types.
pipeline, seeMaterials and Methods. There is a statistically significant difference in nociception perception
between the ibuprofen and the control worms. The difference is most significant when the actual laser
current is around 100-110 mA. This coincide with our observation from Fig. 2 (A) that the most sensitive
region of maximum reverse speed is around 100mA. Indeed, at smaller currents, the nociception level is
small, many worms pause, and the behavior cannot be used to reliably estimate the stimulus level. At
high current, the noxious stimulus perception saturates, and all worms behave similarly, again reducing
the ability to disambiguate the applied current level.
This analysis of ibuprofen worms achieves one of our main goals. It proves our ability to reconstruct
stimulus from the behavior, and shows that analgesic effects of pharmacological perturbations can be
quantified from the behavior. At the same time, ∆Imutant turns out to be insignificant in Fig. 7 (B), even
though Fig. 2 (A) suggest that a large statistically significant difference exists between the mutant and
the control behaviors. This failure to detect a significant nociception reduction is because the templated
response model is not very good for the mutant worm; thus our analysis cannot reliably assign a mutant
trajectory on a given trial to a specific nociception level. In other words, the large error bars in Fig. 7
(B) serve as yet another check for self consistency: effects of the mutations cannot be attributed just to
changes in nociception perception.
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Figure 7. Sensed nociception decrease due to treatments. (A) Differences of the inferred laser
current between the control and the ibuprofen datasets, ∆Iibuprofen. Errors represent standard
deviations, estimated with bootstrapping. (B) Similar differences for the mutant worm, ∆Imutant. Error
bars are estimated by bootstrapping. (C) Dependence of the statistical significance of the nociception
level reduction (measured by the Z score) for ibuprofen at 110 mA on the number of ibuprofen trials.
Designing experiments: how many worms?
We expect our analysis to be useable for screening large numbers of chemicals for analgesic action. Since
our approach targets one individual worm at a time, we need to estimate the number of worms needed
to achieve statistical significance in such screening experiments. For this, we fix the number of control
worms, arguing that these must be only analyzed once, and hence a relatively large number of them can
be tested. We then focus on ibuprofen, whose action is analgesic in our experiments, and on the bin at 110
mA, where the worms experience the most significant nociception reduction. There are Nibuprofen,110 = 94
worms in this bin. We randomly sample with replacements n < Nibuprofen,110 worms from among these
ibuprofen-treated worms and repeat our analysis pipeline, estimating the ∆Iibuprofen(n). Resampling 1000
times (both the ibuprofen and the control datasets), we also estimate the variance of ∆Iibuprofen(n), and
hence the Z score as a function of n, which is plotted in Fig. 7 (C). The plot here is an underestimate of
the true Z score since resampling with replacements removes some stimulus values from the dataset, hence
increasing the mismatch between control worms and the paired treated worms. Even with this, Z ≈ 2 is
achieved at n ≈ 60 ibuprofen worms. In other words, in a typical screening experiment, one would need
to test 200 or more worms to build the control model, and then at least ∼ 60 worms additionally for each
treatment condition.
Discussion
Typically the goal of sensory-response experiments is to develop a model that can predict the behavior in
response to the stimuli. Here we wanted to do this in reverse. Our goal was to build a statistical model
of the thermal stimulus from careful measurements of the nociceptive behavior of C. elegans, and to use
this model to infer the changes in the perceived level of “pain” felt by the organism due to perturbation in
the nociception transduction pathway. Given this model, we could then measure changes in nociception
perception due to effects of analgesics and mutations, and use this as a basis to study the mechanism of
nociception transduction in a genetically tractable organism amenable to high-throughput screens. As
a representative data set, we choose to study the standard laboratory C. elegans strain N2, N2 treated
with ibuprofen, and a mutant with defects in TRPV function.
For the model to be successful, we had to meet a number of challenges. Since the worm could not
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communicate its nociception level to us directly we had to infer this level by reading the “body language”
of the worm’s “pain” response. The difficulty with quantifying a behavioral response as a measure of
nociception level is that drugs or mutations can affect locomotory behavior in addition to perturbing
sensory transduction. So in an attempt to deconvolve these effects, we used the entire behavioral profile
instead of making ad hoc measurements and leveraged the fact that nociception responses are typically
highly stereotyped. This resulted in the discovery that the response can be modeled with a velocity profile
template that scales non-linearly in response to an applied laser current. The success of the template in
modeling the stereotyped wild-type nociception response was confirmed by a functional collapse of the
velocity profiles across different nociception levels. This discovery of invariance is important since it not
only allowed us to effectively correlate nociceptive behavior to the stimulus level, but it also allowed us
to determine if the locomotory changes in our thermal nociception assay was due to changes specifically
in the sensory transduction pathway or due to other general locomotory factors. By carefully accounting
for the variation in our data and quantifying how much of this variation is captured by the model, we
showed that the stereotypical behavior is unaffected by ibuprofen, save for changing the amplitude of
the response. Thus this drug application likely reduced the perceived nociception level in the worm. In
contrast, a TRPV mutation changes locomotion in a way that is not as well captured by the template
model. Thus we can be objectively critical about any nociception inference made with this strain.
The model was also useful in determining key experimental parameters for future measurements. After
verification that the model works well with the native and ibuprofen treated stimulus-response data, we
quantified the changes in thermal nociception perception due to ibuprofen treatment. Our modeling
and experimental assessment of thermal nociception identified the optimal stimulus range and required
number of trials to determine statistically significant differences between the inferred current of N2 in
the untreated and treated conditions.
In conclusion, we have built a general model that connects stereotyped behavior to stimulus. With
a language to describe this relationship, it is now possible to study quantitatively the effects of genetics
and chemicals on this sensorimotor behavior. We believe that the utility of the model is quite general and
could be applied to different model system. However, we particularly hope that this work helps further
establish C. elegans as a model for nociceptive research.
Materials and Methods
Worm preparation and experiment design
All worms were grown and maintained under standard conditions [38], incubated with food at 20 ◦C.
Well fed worms were washed twice then gently spun down for 1 minute and the supernatant discarded by
aspiration. For the drug application, 100 µL of ibuprofen in M9 at 100 µM was added to the eppendorf
tube. For the wild-type and mutant data set, M9 was used instead of the drug solution. Worms were
then placed in an incubator for 30 minutes at 20◦C. After that worms were poured onto a seeded agar
plate and transferred to agar assay plates by a platinum wire pick. These assay plates were incubated
at 20◦C for 30 minutes, and then the experimental trials were done within the next 30 minutes. In total
N = 201 worms for the control group, N = 441 worms for the ibuprofen group, and N = 100 worms for
the mutant group (ocr-2(ak47) osm-9(ky10) IV; ocr-1(ak46)) group were tested. The mutant strain was
obtained from the Caenorhabditis Genetics Center.
The thermal nociceptive stimulation instrument has been described previously [30]. In summary, an
infrared laser is directed to heat the head of a freely crawling worm (∼ 0.5mm FWHM) on an agar plate.
The laser pulse is generated with a randomly chosen laser current between 0 to 200 mA, with a duration
of 0.1 s. The heating of the worm is nearly instantaneous, and it is directly proportional to the current,
between 0 and 2 ◦C for the the current range used in our experiments. Worms were stimulated only once
and not reused. The movements of the worms are imaged using a standard stereomicroscope with video
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capture and laser control software written in LabVIEW. For each nociception stimulus trial, a random
worm is selected on the plate and its motion is sampled at 60 Hz for 15 s, and the laser is engaged 1 s
after the start of the video recording.
Data Analysis
The recorded nociceptive response videos were then processed with Matlab to calculate the time series of
the worm centroid motion as described previously [30]. All the worms that were not stimulated near the
head or were not moving forward in the beginning of the video were discarded. Numerical derivatives of
the centroid times series were then taken and filtered with a custom 500 ms Gaussian filter, which was a
one-sided Gaussian at the edges of the recorded time period, becoming a symmetric Gaussian away from
the edges. This removed the noise due to numerical differentiation and also averaged out the spurious
fluctuations in the forward velocity due to the imperfect sinusoidal shapes of the moving worm. We
verified that different choices of the filter duration had little effect on the subsequent analysis pipeline.
The direction of the velocity was determined by projecting the derivative of the centroid time series onto
the head-to-tail vector for each worm, with the positive and negative velocity values denoting forward /
backward motion, respectively.
The filtered velocity profiles needed to be subsampled additionally. This was because the statistical
model of the data, Eq. (8), involved covariance matrices of the active and paused velocity profiles, Σp
and Σa (note that velocity profiles are not temporally translationally invariant due to the presence of
the stimulus, thus the full covariance matrix is needed, and not a simpler correlation function). To
have a full rank covariance matrix, the number of trials must be larger than the number of time points.
Alternatively, regularization is needed for covariance calculation. The autocorrelation function for all
three worm types showed a natural correlation time scale of & 0.2 s, whether the data was pre-filtered
or not. Thus subsampling at frequency > 5 Hz would not result in data loss. Therefore, instead of an
arbitrary regularization, we chose to subsample the data at 12 Hz, leaving us with 37 data points to
characterize the first 3 s of the worm velocity trace after the stimulus application, 1 ≤ t ≤ 4 s since the
start of the trial. Equation (8) additionally needs knowledge of T , the number of effectively independent
velocity measurements in the profile. This is obtained by dividing the duration of the profile by the
velocity correlation time. An uncertainty of such procedure has a minimal effect on the model of the
experiment since it simply changes log likelihoods of models by the same factor, not changing which
model has the maximum likelihood.
We then considered limiting the duration of the velocity profile used in model building: if velocities
at certain time points do not contribute to identification of I, they should be removed to decrease the
number of unknowns in the model that must be determined from data (values of the templates at different
time points). The first candidate for removal was the period of about 10 frames (0.16 s) after the laser
stimulation since worms do not respond to the stimulus so quickly. However, removal of this time period
had a negligible effect on the model performance, and we chose to leave it intact. In contrast, starting
from 3.3 s (2.3 s after the stimulus) the fraction of explainable variance drops to nearly zero (cf. Fig. 5)
since many worms already had turned by this time and resumed forward motion. Therefore, we eventually
settled on the time in the 1.0 . . . 3.3 s range for building the model.
Whenever needed, we estimated variance of our predictions by bootstrapping the whole analysis
pipeline [39]. For this, we created 1000 different datasets by resampling with replacement from the
original control dataset and the mutant / ibuprofen datasets. Control statistical models (the scaling
function f and the velocity templates) were estimated for each resampled control dataset. Standard
deviations of these models were used as estimates of error bars in Fig. 4. For Fig. 7, we additionally
needed to form the closest control / treatment worm pairs. These were formed between the resampled
data sets for all worm types as well. Standard deviations of ∆Itype evaluated by such resampling were
then plotted in Fig. 7 and used to estimate Z scores. Note that such resampling produces data were
control / treatment paired worms have slightly larger current differences than in the actual data; this
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leads to our error bars being overestimates.
Model in Eq. (1) requires knowing P (I). In principle, this is controlled by the experimentalist, and
thus should be known. In our experiments, P (I) was set to be uniform. However, as described above,
some of the worms were discarded in preprocessing, and this resulted in non-uniformly distributed current
samples. To account for this, we used the empirical Pemp(I) in our analysis instead of P (I) = const. In
turn, Pemp(I) was inferred using a well-established algorithm for estimation of one-dimensional continuous
probability distributions from data [40].
Calculating the template velocities, the covariances, and the scaling function
The template for the paused state up is calculated by taking the average of all paused velocity profiles
for each of the three worm datasets. The covariance Σp is then the covariance of the set of the paused
velocity profiles.
For active worms, we start with fixed putative parameter values I1 and I2. We then calculate the
active template ua and the covariance matrix
∑
a by maximizing the likelihood in Eq. (7)
∂
∑Ntype,a
i logP (vi|a, Ii)
∂ua
∝
Ntype,a∑
i
[
vifI1,I2(Ii)− uaf2I1 I2(Ii)
]
= 0, (14)
∂
∑Ntype,a
i logP (vi|a, Ii)
∂Σa
∝
Ntype,a∑
i
[vi − uafI1,I2(Ii)]2 − (Σa)−1 = 0, (15)
where Ntype,a is the number of active worms of the analyzed type. This gives:
ua(I1, I2) =
∑Ntype,a
i=1 vifI1,I2(Ii)∑Ntype,a
i=1 f
2
I1,I2(Ii)
, (16)
Σa =
Ntype,a∑
i
[vi − uafI1,I2(Ii)]2 . (17)
Having thus estimated ua and Σa at fixed parameter values I1, I2, we maximize
∏
i P (vi|a, Ii) over
the parameters using standard optimization algorithms provided by MATLAB. We perform optimization
from ten different initial conditions to increase the possibility that we find a global, rather than the local
maximum.
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